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Casein kinase II is a protein se~ne/thr~onine kinase that exhibits a preference for acidic substrates. Previous studies have demonstrated that a 
giutamic acid 3 amino acids C-terminal (+ 3) to a serine or threonine is required for phosphorylation. To examine the ability of phosphoserine 
and phosphothreonine residues to serve as specificity determinants for casein kinase II, phosphopeptides containing either of these phosphoamino 
acids in the f3 position were synthesized and tested as substrates. Phosphopeptides containing phosphoserine in the +3 position were readily 
phosphorylated. In contrast, corresponding phosphothreonine-containing peptides were very poorly phosphorylated. These results imply that prior 
phosphorylation of substrate proteins on serine, but not threonine residues, may be important in regulating their phosphorylation by casein kinase 
II. 
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1. INTRODUCTION 
The majority of the protein kinases that have been 
characterized to date can be divided into two 
categories: the protein serineithreonine kinases [l] and 
the protein tyrosine kinases [2]. Within these 
categories, several of the protein kinases can be 
distinguished on the basis of their substrate specificity. 
The ability of particular protein kinases to 
phosphorylate a specific amino acid residue is at least 
in part determined by the primary amino acid sequence 
of the substrate protein. Considerable information 
about the primary sequence requirements for substrate 
phosphorylation has been obtained from studies using 
synthetic peptides. This approach has been successfully 
utilized for several protein serine/threonine kinases in- 
cluding casein kinase II [3-71. 
Casein kinase II is a messenger-independent protein 
serine/threonine kinase found in the cytosol and 
nucleus of all eukaryotic cells [ 1,8,9]. A number of 
substrates have been identified as targets for this 
multifunctional enzyme, including a number of 
metabolic enzymes, some cytoskeletal and contractile 
proteins and a variety of proteins involved in the 
regulation of transcription and translation [8-121. 
Previous studies using synthetic peptides have 
demonstrated that acidic amino acids C-terminal to the 
phosphorylatable serine/threonine are important 
specificity determinants [3-71. Although multiple 
acidic residues are advantageous, a single acidic amino 
acid three residues C-terminal (+3 position) to the 
serinejthreonine is required for phosphorylation. More 
recently, studies with partially dephospho~lated 
phosphoproteins or phosphopeptides have indicated 
that phosphoserine can also serve as a specificity deter- 
minant for casein kinase II [13,14]. The goal of the 
study presented here was to systematically examine the 
ability of phosphoserine or phosphothreonine in the 
+3 position to serve as a specificity determinant for ca- 
sein kinase II. For this study, a series of eight novel 
peptides and phosphopeptides was synthesized and 
tested as substrates for purified bovine testis casein 
kinase II. To relate the results of this study to previous 
studies, the specific casein kinase II substrate peptide 
RRREEETEEE or the related peptide RRREEESEEE 
were used as parent peptides [5,7]. The data indicate 
that phosphoserine in the +3 position can serve as a 
specificity determinant for casein kinase II. However, 
a peptide with a phosphothreonine in the +3 position 
is not phosphorylated by casein kinase II when examin- 
ed under the same conditions. 
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98195, USA 2. MATERIALS AND METHODS 
2.1. Synthetic peptides 
Abbreviations: TFA, trifluoroacetic acid; hoc, t-butoxycarbonyl; 
HOBt, I-hydroxybenzotriazole; DIC, 1,3-diisopropylcarbodiimide 
2.1.1. Solid phase synthesis and characterization 
Peptides were synthesized from Boc-amino acids using an 
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automated synthesizer (model PSSIO, Applied Protein Technologies, 
Cambridge, MA). The side-chain functional groups were protected as 
follows: tosyl for arginine, benzyl for serine and threonine and 
diphenyl phosphotriester for phosphoserine and phosphothreonine. 
Syntheses were performed at the 0.3 mmol scale in a 24 ml reaction 
vessel using Pam resin and the DIC/HOBt coupling strategy as 
described 1151. Automated monitoring assured a minimum efficiency 
of 99.5% at each step. Identity of the peptides was verified by amino 
acid analysis and fast atom bombardment mass spectroscopy [15]. 
to ensure that the phosphorylation reaction was linear for at least 
10 min. 
2.4. Other procedures 
Kinetic constants were determined from Lineweaver-Burke plots 
that were analysed by linear regression using Cricket Graph (Cricket 
Software, Philadelphia, PA). Peptide concentrations were determin- 
ed by amino acid analysis and casein kinase II concentrations were 
determined by the method of Bradford [17]. 
2.1.2. HF cleavage of phosphopeptide from resin and removal of 3. RESULTS 
blocking groups 
Synthetic peptides (0.15 mmol) were cleaved from the resin using 
anhydrous HF/anisole (1: 1, v/v) for 45 min at 0°C. Reagents were 
evaporated and the crude peptides, still retaining their phenyl- 
phosphate blocking groups were extracted using 10% acetic acid 
(200 ml). Each phenyl-protected peptide was dissolved in 2 ml of 
40% TFA/acetic acid, and 72 mg (1 eqv.) of amorphous platinum 
(IV) oxide was added. Hydrogenolysis was performed for 24 h at 
room temperature under 4.05 bar (4 atm) of hydrogen pressure. The 
mixture was evaporated to dryness under vacuum, suspended in 
water, and the catalyst removed by filtration. 
2.1.3. Peptide purification 
Phosphorylated peptides were purified by preparative HPLC on a 
Whatman Partisil 10 ODS-3 column (22 x 250 mm) using a 
Beckman/Altex HPLC. Elution was performed with a linear gradient 
from 0.1% aqueous TFA to 30-40% acetonitrile-isopropanol (2: 1) 
containing 0.1% TFA in 40 min at 14 ml/min with the eluent 
monitored at 220 nm, AUFS = 0.3. Phosphopeptides were separated 
from any unphosphorylated peptide or by-products by affinity 
chromatography on a Fe “+-Chelex column as described in detail 
elsewhere [IS]. 
Synthetic peptides and phosphopeptides that are 
variants of RRREEETEEE and RRREEESEEE [5,7] 
have been used to systematically examine the ability of 
phosphoserine or phosphothreonine in the +3 position 
to serve as specificity determinants for casein kinase II. 
As a basis for comparison, peptides containing either 
glutamic acid, alanine or the unphosphorylated 
hydroxy-amino acids serine and threonine in the +3 
position were examined (table 1). The kinetic 
parameters (Km and kc& for the phosphorylation of 
each of the peptides by casein kinase II are reported in 
table 2. A ratio of the phosphorylation rate and 
substrate concentration dependence (&/K,,,) serves as 
a comparative index for the various peptides as 
substrates. 
Analytical HPLC was performed on a reverse phase Whatman 
Partisil 5,ODS-3 column (4.6 x 250 mm) using a linear gradient of 
aqueous 0.1% HsP04 to 0.1% HsP04 in acetonitrile over 40 min at 
1 ml/min with the eluent monitored at 210 nm with AUFS = 0.25 
and on Waters cation exchange cartridge (Partisil SCS 8 mm x 
10 cm) with a gradient from 10% acetonitrile in 0.01 M potassium 
phosphate, pH 3.5 to 10% acetonitrile in 0.4 M sodium phosphate, 
pH 2.5 over 40 min. 
2.1.4. Other peptides 
As expected from previous studies, replacement of 
an alanine with a glutamic acid in the +3 position 
results in a dramatic improvement in peptide 
phosphorylation (RRREEESAAA vs RRREEESAAE) 
[6,7]. This is evidenced by large increases in relative 
phosphorylation (table 1) and in the kcat/Km ratio (table 
2). A large increase (lo-fold) in relative phosphoryla- 
tion rate (table 1) is also observed when a serine is 
replaced with a phosphoserine (RRREEESAASA vs 
RRREEESAAS(P)A and RRREEETAASA vs 
The peptide RRREEETEEE was obtained from Peninsula 
Laboratories. The syntheses of RRREEESAAA and RRREEESAAE 
were performed by Dr P. Chou and H. Zebroski of the Chemical 
Synthesis Faculty of the Howard Hughes Medical Institute at the 
University of Washington. The synthesis and purification of these 
peptides was previously described [7]. 
Relative rates of peptide and phosphopeptide phosphorylation by 
casein kinase II 
2.2. Purification of casein kinase II 
Casein kinase II was purified to homogeneity from bovine testis by 
modification of methods previously described [16]. The kcat of this 
preparation for RRREEETEEE, a specific synthetic peptide 
substrate of casein kinase II, was 1.55 Fmol phosphate transfer- 
red/min/mg enzyme when assayed using the conditions described 
below. 
2.3. Casein kinase II assays 
The phosphorylation of synthetic peptides by casein kinase II was 
performed as described [5,7]. Briefly, assays were performed at 30°C 
in a final volume of 30 pl and contained the following: 50 mM Tris- 
Cl, pH 7.6, 1.50 mM NaCl, 10 mM MgCh, 0.1 mM ATP (spec. act. 
500-1000 cpm/pmol), 0.2 mg/ml bovine serum albumin and the in- 
dicated amount of synthetic peptide. Assays were commenced by ad- 
dition of enzyme and were terminated by spotting 20~1 of the 
reaction mixture on phosphocellulose paper (Whatman, P81). The 
papers were immediately washed in 150 mM phosphoric acid as 
previously described [5,7]. Casein kinase II was diluted prior to assay 
Peptide Relative phosphorylation rate 
RRREEETEEE 100 
RRREEESAAA 4 
RRREEESAAE 190 
RRREEESAASA 6 
RRREEESAAS(P)A 64 
RRREEETAASA 1 
RRREEETAAS(P)A 11 
RRREEESAATA <l 
RRREEESAAT(P)A 5 
RRREEETAATA 1 
RRREEETAAT(P)A <I 
Assays were conducted as described in section 2 using each peptide 
at a concentration of 2 mM. Data were compiled from six separate 
experiments. From these experiments, the actual specific activity of 
casein kinase II towards RRREEETEEE was 0.85 f 0.07 Fmol 
phosphate transferred/min/mg (average f SE) 
118 
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Table 2 
Kinetic constants for casein kinase II phosphorylation of synthetic 
peptides 
Peptide k CBf 
&mol/ Cl%) 
&at/G Relative 
k&K, 
min/mg) 
RRREEETEEE 1.55 0.56 2.77 100 
RRREEESAAA 0.13 4.88 0.03 1 
RRREEESAAE 2.81 0.96 2.93 106 
RRREEESAASA 0.35 7.67 0.05 2 
RRREEESAAS(P)A 1.20 0.57 2.11 76 
RRREEETAASA n.d. n.d. 
RRREEETAAS(P)A 0.24 0.85 0.28 10 
RRREEESAATA 0.03 3.33 0.01 <1 
RRREEESAAT(P)A 0.16 4.16 0.04 1 
RRREEETAATA 0.02 1.93 0.01 <1 
RRREEETAAT(P)A 0.03 10.49 <O.Ol <1 
Phospho~lation was monitored and kinetic constants determined as 
described in section 2; n.d., not determined 
RRREEETAAS(P)A). The kcat/Km ratios for these 
peptides (table 2) demonstrate that this effect is even 
greater than indicated by the relative phosphorylation 
rates. 
A peptide containing a phosphorylatable serine is 
more readily phosphorylated than the corresponding 
threonine-containing peptide (RRREEESAAS(P)A vs 
RR~EET~S(P)A). This preference for serine over 
threonine by casein kinase II has been noted in previous 
studies [6,7]. 
The data in table 2 clearly demonstrate that glutamic 
acid or phosphoserine, but not phosphothreonine, in 
the +3 position can serve as a specificity determinant 
for casein kinase II. Although the kcat for 
RRREEESAAE is significantly greater than that for 
RRREEESAAS(P)A, the former peptide also has a 
higher Km. Therefore, the kcat/Km ratio of 
RR~EES~S(P)A is only moderately lower than that 
of RRREEESAAE. This suggests that phosphoserine 
and glutamic acid have a similar capacity to serve as 
specificity determinants for casein kinase II, at least in 
the +3 position. By comparison, even the best of the 
phosphot~eo~ne-contai~ng peptides (RRREEE- 
SAAT(P)A) had a IO-fold lower phosphorylation rate 
than the corresponding phosphoserine-containing pep- 
tide (RRREEESAAS(P)A). The kinetic constants for 
the two peptides also illustrate this point since the 
kc,/&, ratio for the phosphothreonine-containing pep- 
tide was more than 50-fold lower than that of its 
phosphoserine-containing counterpart. 
4. DISCUSSION 
The observations presented here extend those of two 
previous reports that demonstrated that casein kinase II 
can use partially dephosphorylated phosvitin [13] or 
phosphotripeptide [14] as substrates. In the previous 
reports, the position of the phosphoserine residue with 
respect to the phosphorylatable residue was not defin- 
ed. Furthermore, the K,, of the partially 
dephosphorylated tripeptide was approximately 5-fold 
higher than that observed in this study with 
RRREEESAAS(P)A. 
The inability of phosphothreonine to function as a 
specificity determin~t may provide valuable insight in- 
to mechanisms of substrate recognition by casein 
kinase II. Clearly, a model stating that a negatively 
charged residue in the +3 position will have a positive 
effect on phosphorylation is not entirely correct. The 
methyl group on the p carbon of threonine could im- 
pair interactions between the phosphate group on the 
substrate and casein kinase II. Based on the results of 
this study, it will clearly be of interest to examine the 
ability of phosphotyrosine or even the N- 
phosphorylated amino acids (phosphohistidine, 
phospholysine, phosphoarginine) as specificity deter- 
minants for casein kinase II. 
The demonstration that at least one type of 
phosphoamino acid can have a positive influence on 
phosphorylation by casein kinase II has some in- 
teresting implications. Casein kinase II joins casein 
kinase I [ 181 and glycogen synthase kinase-3 [ 1 g-231 as 
protein serine/threonine kinases that can utilize 
phosphoserines as specificity determinants. The ability 
to utilize phosphoserine in such a manner suggests the 
potential for synergistic phosphorylations where prior 
phosphorylation of a substrate by one protein kinase 
permits phosphorylation by a second enzyme. Indeed, 
casein kinase II is known to participate in the 
synergistic phosphorylation of glycogen synthase 
[19-211, the RI1 regulatory subunit of CAMP- 
dependent protein kinase [22], and inhibitor 2 of pro- 
tein phosphatase 1 [23]. Prior phosphorylation of 
either protein by casein kinase II is obligatory for 
subsequent phosphorylation by glycogen synthase 
kinase 3. On the basis of the results presented here and 
elsewhere, it is probable that casein kinase II wili also 
phosphorylate some proteins only after phosphoryla- 
tion by another protein kinase. 
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